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Aim. The aim of this study was to evaluate the presence of the cytokines tumor necrosis factor-alpha (TNF-α) and interleukin-6
(IL-6) in human periapical lesions. Subjects and methods. Samples were obtained from three groups of teeth: symptomatic teeth,
asymptomatic lesions, and uninﬂamed periradicular tissues as a control. Results. TNF-alpha levels were signiﬁcantly increased in
symptomatic lesions compared to control. Group with asymptomatic lesions had signiﬁcantly higher concentrations compared to
control. There were no signiﬁcant diﬀerences in TNF-alpha levels between symptomatic and asymptomatic lesions. In group with
symptomaticlesions,IL-6levelsweresigniﬁcantlyhigherthaningroupwithasymptomaticlesions.TheIL-6levelsinsymptomatic
groupalsoshowedsigniﬁcantlyhigherconcentrationincomparisonwithcontrolgroup.Inasymptomaticgroup,theIL-6levelhad
signiﬁcantly higher concentrations compared to control. Conclusion. These results indicate that symptomatic lesions represent an
immunologically active stage of disease, and asymptomatic lesions are the point from which the process advances toward healing.
Copyright © 2007 Ivana Brekalo Prˇ so et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1. INTRODUCTION
Periapical inﬂammatory lesions are a frequent pathology
and, in most cases, a consequence of dental caries. This type
of lesion develops as an immune reaction triggered by the
presence of bacteria in the root canal and bacterial toxins
in the periapical region [1]. After microbial invasion of pe-
riapical tissues, both nonspeciﬁc and speciﬁc immunologic
responses persist in the host tissues. This inﬂammatory pro-
cess ultimately results in destruction of the alveolar bone
surrounding the tooth. It is characterized by the presence
of immunocompetent cells producing a wide variety of in-
ﬂammatory mediators. TNF-alpha is a soluble mediator and
is released from immunocompetent cells in inﬂammatory
processes. TNF-alpha plays an important role in initiating
and coordinating the cellular events that make up the im-
mune system’s response to infection. The biological eﬀects
of TNF-alpha include activation of leukocytes such as lym-
phocytes (T and B cells), macrophages, and natural killer
cells; fever induction; acute-phase protein release; cytokine
and chemokine gene expression; and endothelial cell acti-
vation [2]. IL-6 is a pleotropic cytokine that inﬂuences the
antigen-speciﬁc immune responses and inﬂammatory reac-
tions. It stimulates the formation of osteoclast precursors
from colony-forming unit-granulocyte-macrophage and in-
creases number of osteoclasts in vivo, leading to systemic in-
crease in bone resorption. Emerging data suggests that IL-6
alsohassigniﬁcantanti-inﬂammatoryactivities[3].Together
with IL-1 and TNFα (which also stimulate IL-6 secretion),
it belongs to the group of main proinﬂammatory cytokines
[4].
The inﬂammatory response in the persisting apical le-
sion protects the host from further microbial invasion. The
pathogenic pathways linking infection with development of
a periapical lesion and concomitant bone resorption are not
fully understood. Large numbers of immunocompetent cells
suchasmacrophages,activatedTandBcellsandplasmacells
synthesizing all classes of immunoglobulins are present in
periapical lesions [5].
The various activities of IL-6 and TNF-alpha suggest that
these factors could play a major role in mediation of the in-
ﬂammatory and immune responses initiated by infection or
injury [6]. The aim of this study was to determine the TNF-
alpha and IL-6 levels in symptomatic and asymptomatic2 Mediators of Inﬂammation
periapical lesions using an enzyme-linked immunosorbent
assay (ELISA) in surgically removed human periapical le-
sions.
2. SUBJECTS AND METHODS
A total number of 45 teeth were included in this study. The
teethweredividedintothreegroups.Group1consistedofle-
sions from 15 teeth that had been diagnosed as symptomatic.
Teeth were put in this group based on the following crite-
ria: clinical and radiographic examination that determined
the existence of periradicular pathosis involving destruction
of cortical bone and painful sensitivity to percussion and/or
palpation [5].
Group 2 consisted of lesions from 15 teeth that had been
diagnosed as asymptomatic. A diagnosis was made based on
the following criteria: clinical and radiographic examination
that determined the existence of periradicular pathosis in-
volving destruction of cortical bone, no or slight sensitivity
to percussion.
Group 3 consisted of uninﬂamed periradicular tissues
that were obtained from periapical regions of 15 unerupted
and incompletely formed third molars. The teeth included in
this group had to meet the following criteria: a verbal his-
tory conﬁrming no history of pulpal pain, clinical and ra-
diographic examination after extraction assuring that these
teeth had no caries.
Clinical examination was performed according to the
standard clinical criteria. After informed consent had been
obtained and medical, dental, and social histories collected,
tissues were obtained by apicoectomy. The diameter of the
lesions, determined on the radiographs, ranged from 2mm
to 16mm.
The surgery was performed with the patients under local
anesthesia. The patients involved in this study had not suf-
fered from any diseases requiring any form of medical treat-
ment except for dental surgery. These patients did not re-
ceive any medications including salicylates, nonsteroid anti-
inﬂammatory drugs, or antibiotics for about 1 month prior
to surgery. After excision of the lesion, each specimen was
divided into two. One section was taken for histopatho-
logical evaluation and was stained with hematoxylin and
eosin. Histological examination showed that 25 tissue sam-
ples were granulomas comprising of connective tissue with
variable collagen density, inﬂammatory inﬁltrate predomi-
nantly of macrophages, lymphocytes, and groups of plas-
mocytes, polymorphonucleocytes and giant cells, as well as
the presence of ﬁbroangioblastic proliferation in variable de-
grees.Threelesionswerediagnosedasscartissue.Twolesions
presented connective tissue with variable diﬀuse inﬂamma-
tory inﬁltrate and cavity formation limited by continuous
or discontinuous stratiﬁed squamous epithelium, and thus
were considered inﬂammatory cysts. In the samples of symp-
tomatic lesions, there was a presence of polymorphonuclear
cells, more than in asymptomatic lesions.
Before homogenization every sample was weighed. For
cytokine analysis, the tissue was cut up ﬁnely with scissors
and homogenized in a glass tissue grinder with a Teﬂon
plunge.Theelutionswereperformedat4◦Co v era30min ut e
period with mixing before centrifugation for 2 minutes at
9880g. The concentrations of TNF-alpha and IL-6 were ana-
lyzed with a commercial enzyme-linked immunosorbent as-
say kit (ELISA; R&D, Minneapolis, Minn, USA). The assay
was performed according to the manufacturer’s instructions
and the results are expressed in pg/mL. The detection limit
for TNF-alpha was 4.4pg/mL and 1.4pg/mL for IL-2, re-
spectively. Results of the protein content were expressed in
log10pg/mL.
All subjects were informed of the aims and procedures of
research, as well as of the fact that their medical data would
be used in research. Within the research they were guaran-
teed respect of their basic ethical and bioethical principles—
personal integrity (independence, righteousness, well-being,
and safety) as regulated by N˝ urnberg codex and the most re-
cent version of Helsinki declaration. Only those subjects who
have given a written permission in form of informed consent
were included.
3. STATISTICAL ANALYSIS
Data are presented as median values, interquartile range
(IQR) and on a logarithmic scale. The results obtained were
compared using the nonparametric Kruskal-Wallis test and
Mann-Whitney as a post-hoc test.
All statistical values were considered signiﬁcant at the P
levelof.05.Statisticalanalysisofdatawasperformedbyusing
Statistica for Windows, release 6.1 (StaSoft Inc., Tulsa, Okla,
USA).
4. RESULTS
This study quantiﬁed the levels of TNF-alpha and IL-6 in
symptomatic and asymptomatic human periapical lesions.
Lesions were also categorized by the size and histological
ﬁndings.
The levels of TNF-alpha and IL-6 were measured in the
symptomatic and asymptomatic human periapical lesions as
well as in the control group, and are presented as the me-
dian (IQR) on a logarithmic scale in Figures 1 and 2. Median
value for TNF-alpha in the symptomatic group: 4.47 (IQR:
4.44–4.61) pg/mL was signiﬁcantly higher (P<. 001) com-
pared to 3.96 (IQR: 3.86–4.10) pg/mL in control group. Me-
dian value of TNF-alpha in the asymptomatic group: 4.46
(IQR: 4.28–4.60) pg/m was also signiﬁcantly higher (P<
.001), compared to 3.96 (IQR: 3.86–4.10) pg/mL in con-
trol group. There was no signiﬁcant diﬀerence in TNF-alpha
level between symptomatic and asymptomatic lesions: me-
dian 4.48pg/mL versus 3.91pg/mL (P = .418). (Figure 1).
5. DISCUSSION
Periapical lesions usually result from a persistent inﬂamma-
tory response induced by prolonged exposure of periapical
tissues to various microbial agents, evoking an immunologi-
calreaction.Inthislocaldefensemechanism,variousinﬂam-
matorymediators,inparticularinﬂammatorycytokinesIL-6
andTNF-alpha,playacomplexandcentralroleinregulation
of the immune response.Ivana Brekalo Prˇ so et al. 3
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Figure 1: Graphic representation of median TNF-alpha concen-
trations in symptomatic, asymptomatic, and control groups. Data
represent the median log10 cytokine contents (IQR) per milliliter.
Signiﬁcance: symptomatic group compared to control: median 4.47
(IQR: 4.44–4.61) pg/mL versus 3.96 (IQR: 3.86–4.10) pg/mL; P<
.001. Group with asymptomatic lesions compared to control: me-
dian 4.46 (IQR: 4.28–4.60) pg/mL versus 3.96 (IQR: 3.86–4.10)
pg/mL; P<. 001.
The immune complex is formed by cells whose main
function is to recognize antigens that penetrate the organ-
ismandtoneutralizeand/ordestroythem[7].IL-6hasmany
molecular forms and each molecule has a diﬀerent function
when secreted by diﬀerent cells in distinct situations (acti-
vated through diverse stimuli). Several studies have shown
that both humoral and cellular immune responses play im-
portant roles in the pathogenesis of periapical lesions [8].
The cytokine expression has been investigated in periapical
lesions, however, the role that these molecules may play in
the pathogenesis of the disease has not been well established.
The inﬂammatory cytokines IL-6 and TNF-alpha have
been demonstrated to have the capacity to activate osteoclas-
tic bone resorption [9].
The mediators involved in the inﬂammatory process and
bone resorption appear to be more complex. Thus, human
and animal studies have demonstrated the active participa-
tion of other cytokines, such as TNF-alpha, IL-6, IL-3, GM-
CSF, IL-11, IL-17, and IL-18, which have shown their po-
tential role in the pathogenesis of osteolytic diseases [9, 10].
These cytokines might be acting synergistically with IL-1,
promoting activation/diﬀerentiation of osteoclasts and pro-
duction/secretion of prostaglandins by many cell types, in-
cluding ﬁbroblasts and osteoblasts [10]. IL-6 has tradition-
allybeenconsideredtobeaproinﬂammatorymediator,since
it is induced by IL-1 and TNF-alpha early in the inﬂamma-
tory cascade, and because it stimulates expression of acute-
phase proteins [3].
Our results demonstrate the presence of IL-6 in the vast
majority of tissue samples and are in agreement with those
from previous studies [11]. It has been reported that cystic
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Figure 2: Graphic representation of median IL-6 concentrations in
periapical lesions according to clinical diagnosis. Data represent the
median log10 cytokine contents (IQR) per mililliter. Signiﬁcance:
symptomatic and asymptomatic groups: median 4.60pg/mL ver-
sus 4.48pg/mL; P = .002. Symptomatic group and control group:
median 4.60pg/mL versus 3.91pg/mL; P<. 001. Asymptomatic
group compared to control: median 4.48pg/mL versus 3.91pg/mL;
P<. 001.
growth may be due to the autocrine stimulation of cyst ep-
ithelial cell proliferation by TNF-alpha and IL-6, and the os-
teolytic activity of these cytokines, causing local bone loss
[6]. In this study, the concentrations of IL-6 in the symp-
tomatic lesions were statistically signiﬁcantly in correlation
with asymptomatic lesions and control group. These results
suggest that these lesions may represent an active state of
inﬂammatory periradicular disease which has already been
conﬁrmed [11, 12]. The plasma concentration of IL-6 has
also been reported to correlate with severity of infection in
certain clinical pathologic conditions [12] .T h el e v e l so fI L - 6
have also been measured in the patients with atypical painful
disorders in orofacial region, and their levels were signiﬁ-
cantly greater than those in control group [13].
Results from the previous studies conﬁrm the results ob-
tainedinthisstudy,sinceithasbeenprovedatdiﬀerentlevels
that IL-6 is signiﬁcantly increased in certain infections and
painful conditions. In researches performed to the present
date, it has been proved that both IL-6 and TNF-alpha are
produced in response to infectious organisms, in vitro and
invivoconditions.Onceproduced,theycouldexertabeneﬁ-
cial or deleterious eﬀect, depending on the quantity in which
they are produced and the time period over which produc-
tion is sustained [3].
In our study, TNF-alpha and IL-6 were detected in all
of the periapical samples. Highest concentration of TNF-
alpha was detected in symptomatic and asymptomatic le-
sions, while lowest TNF-alpha concentration was found in
healthy samples. Somewhat greater concentration was found
in symptomatic lesions, but there was no statistically sig-
niﬁcant diﬀerence between symptomatic and asymptomatic4 Mediators of Inﬂammation
groups.Statisticallysigniﬁcantdiﬀerencewasfoundinsymp-
tomatic and asymptomatic groups in comparison with the
control group shows clearly that TNF-alpha is an impor-
tant bone-resorptive mediator and its elevated levels have
far-reaching systemic consequences. Inﬂammatory cytokines
also play a part in the modulation of pain by interfering
with nociceptive transduction, conduction, and transmis-
sion. This modulation may result from alteration of the tran-
scription rate and post-translational changes in proteins in-
volved in the pain pathway. In the previous study, an impor-
tant role was assigned to IL-6 in the physiology of nocicep-
tion and the pathophysiology of pain [14]. Because of this
fact, we wanted to analyze the correlation between tissue cy-
tokine levels and characteristic features of the lesions, such
as symptoms. Samples in Group 1 represent a symptomatic
group. The elevated IL-6 and TNF-alpha levels in this group
suggest that these lesions could represent an active state of
inﬂammatory periradicular disease. In Group 2 which is the
asymptomaticgroup,wefoundsigniﬁcantlyelevatedlevelsof
bothcytokines,comparedtothecontrolgroup.However,the
diﬀerence in IL-6 level between this group and both symp-
tomaticandcontrolgroupswasstatisticallysigniﬁcant.These
results suggest that inﬂammatory reaction is less intense in
tissues categorized in Group 2.
The present results suggest that a chronic bacterial chal-
lenge from infected root canal causes the expression of two
important cytokines, TNF-alpha and IL-6, which play a key
role in periapical pathogenesis as potent bone resorption-
stimulating mediators.
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